Dietary Methionine Restriction Increases Fat Oxidation in Obese Adults with Metabolic Syndrome

Objective:In preclinical reports, restriction of dietary methionine intake was shown to enhance metabolic flexibility, improve lipid profiles, and reduce fat deposition. The present report is the outcome of a “proof of concept” study to evaluate the efficacy of dietary methionine restriction (MR) in...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 96; no. 5; pp. E836 - E840
Main Authors Plaisance, Eric P., Greenway, Frank L., Boudreau, Anik, Hill, Kasey L., Johnson, William D., Krajcik, Rozlyn A., Perrone, Carmen E., Orentreich, Norman, Cefalu, William T., Gettys, Thomas W.
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.05.2011
Copyright by The Endocrine Society
Endocrine Society
Subjects
Online AccessGet full text
ISSN0021-972X
1945-7197
1945-7197
DOI10.1210/jc.2010-2493

Cover

More Information
Summary:Objective:In preclinical reports, restriction of dietary methionine intake was shown to enhance metabolic flexibility, improve lipid profiles, and reduce fat deposition. The present report is the outcome of a “proof of concept” study to evaluate the efficacy of dietary methionine restriction (MR) in humans with metabolic syndrome.Methods:Twenty-six obese subjects (six male and 20 female) meeting criteria for metabolic syndrome were randomized to a diet restricted to 2 mg methionine/kg body weight per day and were provided capsules containing either placebo (n = 12) or 33 mg methionine/kg body weight per day (n = 14). Energy expenditure, body composition, insulin sensitivity, and biomarkers of metabolic syndrome were measured before and after 16 wk on the respective diets.Results:Insulin sensitivity and biomarkers of metabolic syndrome improved comparably in both dietary groups. Rates of energy expenditure were unaffected by the diets, but dietary MR produced a significant increase in fat oxidation (MR, 12.1 ± 6.0% increase; control, 8.1 ± 3.3% decrease) and reduction in intrahepatic lipid content (MR liver/spleen attenuation ratio, 8.1 ± 3.3% increase; control ratio, 2.2 ± 2.1% increase) that was independent of the comparable reduction in weight and adiposity that occurred in both groups.Conclusions:Sixteen weeks of dietary MR in subjects with metabolic syndrome produced a shift in fuel oxidation that was independent of the weight loss, decreased adiposity, and improved insulin sensitivity that was common to both diets.
Bibliography:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Report-1
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Undefined-3
ISSN:0021-972X
1945-7197
1945-7197
DOI:10.1210/jc.2010-2493